Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000667760 | SCV000792261 | pathogenic | Fanconi anemia complementation group A | 2017-06-13 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001065334 | SCV001230290 | pathogenic | Fanconi anemia | 2023-07-25 | criteria provided, single submitter | clinical testing | This premature translational stop signal has been observed in individuals with Fanconi anemia (PMID: 24584348, 26740942, 29098742). This variant is present in population databases (no rsID available, gnomAD 0.002%). This sequence change creates a premature translational stop signal (p.Asp944Glyfs*5) in the FANCA gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FANCA are known to be pathogenic (PMID: 19367192). ClinVar contains an entry for this variant (Variation ID: 552489). For these reasons, this variant has been classified as Pathogenic. |
Genetic Services Laboratory, |
RCV001816670 | SCV002072102 | pathogenic | not provided | 2017-07-28 | criteria provided, single submitter | clinical testing | This sequence change results in an amino acid frameshift and creates a premature stop codon 4 amino acids downstream of the mutation, p.Asp944Glyfs*5. This pathogenic sequence change is predicted to result in an abnormal transcript, which may be degraded, or may lead to the production of a truncated FANCA protein with potentially abnormal function. This pathogenic sequence change has previously been described in patients with Fanconi anemia (Morgan NV, et al., 1999; Savino M et al., 1997; De Rocco D et al., 2014; Nicchia E, et al., 2015). |
Fulgent Genetics, |
RCV000667760 | SCV002793003 | pathogenic | Fanconi anemia complementation group A | 2022-04-22 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000667760 | SCV004196047 | pathogenic | Fanconi anemia complementation group A | 2024-01-11 | criteria provided, single submitter | clinical testing | |
Leiden Open Variation Database | RCV000667760 | SCV001425693 | pathogenic | Fanconi anemia complementation group A | 2020-02-28 | no assertion criteria provided | curation | Curator: Arleen D. Auerbach. Submitters to LOVD: Arleen D. Auerbach, Johan de Winter, Sue Richards. |
Natera, |
RCV000667760 | SCV001452858 | pathogenic | Fanconi anemia complementation group A | 2020-09-16 | no assertion criteria provided | clinical testing |